These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 31849179)
21. Micelle-Enhanced conventional and synchronous spectrofluorimetric methods for the simultaneous determination of lesinurad and febuxostat: Application to human plasma. Magdy G; Belal FF; Abdel-Megied AM; Abdel Hakiem AF Spectrochim Acta A Mol Biomol Spectrosc; 2021 Mar; 248():119239. PubMed ID: 33310619 [TBL] [Abstract][Full Text] [Related]
22. Micellar-based spectrofluorimetric method for the selective determination of ledipasvir in the presence of sofosbuvir: application to dosage forms and human plasma. Abdel-Lateef MA; Ali R; Omar MA; Derayea SM Luminescence; 2020 Jun; 35(4):486-492. PubMed ID: 31869004 [TBL] [Abstract][Full Text] [Related]
23. Selective spectrofluorimetric method for determination of Lisinopril in pharmaceutical preparations and in presence of hydrochlorothiazide: Application to content uniformity testing. Derayea SM; Badr El-Din KM; Mohammed FF Luminescence; 2017 Dec; 32(8):1482-1487. PubMed ID: 28681525 [TBL] [Abstract][Full Text] [Related]
24. Determination of Ondansetron by Spectrofluorimetry: Application to Forced Degradation Study, Pharmaceuticals and Human Plasma. Gayatri SN; Biju VMN; Starvin AM J Fluoresc; 2019 Jan; 29(1):203-209. PubMed ID: 30483905 [TBL] [Abstract][Full Text] [Related]
25. Spectrofluorimetric Determination of Topiramate and Levetiracetam as Single Components in Tablet Formulations and in Human Plasma and Simultaneous Fourth Derivative Synchronous Fluorescence Determination of their Co-Adminstered Mixture in Human Plasma. El-Yazbi AF; Wagih MM; Ibrahim F; Barary MA J Fluoresc; 2016 Jul; 26(4):1225-38. PubMed ID: 27147226 [TBL] [Abstract][Full Text] [Related]
26. Fluorescence spectroscopy method for estimation of Ivabradine in bulk and the tablet dosage form. Tailor PM; Naik K Spectrochim Acta A Mol Biomol Spectrosc; 2022 Jan; 264():120330. PubMed ID: 34481253 [TBL] [Abstract][Full Text] [Related]
27. Validated spectrofluorimetric method for determination of two phosphodiesterase inhibitors tadalafil and vardenafil in pharmaceutical preparations and spiked human plasma. Abu El-Enin MA; Al-Ghaffar Hammouda Mel-S; El-Sherbiny DT; El-Wasseef DR; El-Ashry SM Luminescence; 2016 Feb; 31(1):173-8. PubMed ID: 26019060 [TBL] [Abstract][Full Text] [Related]
28. Design and strategy for spectrofluorimetric determination of tranexamic acid in its authentic form and pharmaceutical preparations: application to spiked human plasma. Anwer EF; Nour El-Deen DAM; Omar MA Luminescence; 2021 Aug; 36(5):1327-1334. PubMed ID: 33955136 [TBL] [Abstract][Full Text] [Related]
29. Study on fluorescence properties of HCV antiviral (velpatasvir) and its fluorimetric determination in presence of sofosbuvir; application to stability study and human plasma. Omar MA; Abdel-Lateef MA; Ali R; Derayea SM Luminescence; 2018 Nov; 33(7):1249-1256. PubMed ID: 30144265 [TBL] [Abstract][Full Text] [Related]
30. Highly sensitive spectrofluorimetric procedure for the assay of phenothiazine derivatives in the presence of their sulfoxide oxidized product. Omar MA; Mohamed AM; Nagy DM; Salem H; Abdelmageed OH Luminescence; 2020 Nov; 35(7):1134-1141. PubMed ID: 32696623 [TBL] [Abstract][Full Text] [Related]
31. Orthophthaldehyde as a fluorescent probe for the feasible and sensitive assay of heptaminol: application to dosage forms and real human plasma. Derayea SM; Khashaba PY; Abdelgaleel M; Nagy DM Luminescence; 2022 Feb; 37(2):230-237. PubMed ID: 34791769 [TBL] [Abstract][Full Text] [Related]
32. Micellar enhanced spectrofluorimetric approach for nanogram detection of certain α Omar MA; Hammad MA; Salman BI Luminescence; 2018 Nov; 33(7):1226-1234. PubMed ID: 30094938 [TBL] [Abstract][Full Text] [Related]
33. Micelle-enhanced spectrofluorimetric determination of diphenhydramine: application to human plasma and its simultaneous determination with naproxen in pharmaceutical tablets. Hammad SF; El-Khateeb BZ; El-Malla SF Luminescence; 2021 May; 36(3):733-741. PubMed ID: 33332700 [TBL] [Abstract][Full Text] [Related]
34. Micelle-enhanced spectrofluorimetric method for quantification of entacapone in tablets and human plasma. Belal F; Ibrahim F; Sheribah ZA; Alaa H Luminescence; 2017 Aug; 32(5):713-722. PubMed ID: 27917581 [TBL] [Abstract][Full Text] [Related]
35. An innovational validated spectrofluorimetric technique for determination of 6-Aminocaproic acid in pure form and its tablet: Application to spiked human plasma and urine. Anwer EF; Nour El-Deen DAM; Omar MA Spectrochim Acta A Mol Biomol Spectrosc; 2021 Nov; 261():119984. PubMed ID: 34087772 [TBL] [Abstract][Full Text] [Related]
36. Highly sensitive spectrofluorimetric method for determination of doxazosin through derivatization with fluorescamine; Application to content uniformity testing. Omar MA; Hammad MA; Salman BI; Derayea SM Spectrochim Acta A Mol Biomol Spectrosc; 2016 Mar; 157():55-60. PubMed ID: 26716887 [TBL] [Abstract][Full Text] [Related]
37. Validated sensitive spectrofluorimetric method for determination of antihistaminic drug azelastine HCl in pure form and in pharmaceutical dosage forms: application to stability study. El-Masry AA; Hammouda ME; El-Wasseef DR; El-Ashry SM Luminescence; 2017 Mar; 32(2):177-181. PubMed ID: 27279096 [TBL] [Abstract][Full Text] [Related]
38. Derivative emission spectrofluorimetry: Application to the analysis of newly approved FDA combination of ibuprofen and famotidine in tablets. Ragab MA; El-Kimary EI Luminescence; 2015 Sep; 30(6):760-7. PubMed ID: 25421838 [TBL] [Abstract][Full Text] [Related]
39. New spectrofluorimetric analysis of empagliflozin in its tablets and human plasma using two level full factorial design. Omar MA; Ahmed HM; Batakoushy HA; Abdel Hamid MA Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jul; 235():118307. PubMed ID: 32247255 [TBL] [Abstract][Full Text] [Related]
40. New, sensitive and validated spectrofluorimetric method for the estimation of etoposide in bulk and pharmaceutical formulations. Snehalatha M; Saha RN Pharmazie; 2006 Aug; 61(8):664-6. PubMed ID: 16964705 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]